Bharat Immunological & Biologicals Corporation Share Price

Bharat Immunological & Biologicals Corporation Ltd. key Products/Revenue Segments include Oral Polio Vaccines for the year ending 31-Mar-2022.

For the quarter ended 30-09-2023, the company has reported a Standalone Total Income of Rs .16 Crore, up 60.93 % from last quarter Total Income of Rs .10 Crore and down 99.39 % from last year same quarter Total Income of Rs 26.80 Crore. Company has reported net profit after tax of Rs -4.92 Crore in latest quarter.

The company’s top management includes Dr.Y K Gupta, Dr.Sanjay Kumar Mishra, Dr.Alka Sharma, Dr.Madhu Dikshit, Dr.Mohd Aslam, Mr.Roshan Lal, Dr.Sudhanshu Vrati, Mr.Sandip Kumar Lal. Company has Rasool Singhal & Co. as its auditors. As on 31-03-2024, the company has a total of 4.32 Crore shares outstanding.

Bharat Immunological Share Price Today is Rs. 17.01. On previous day, the Bharat Immunological Share Price (NSE) closed at Rs. 17.14, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2024, the promoter held 59.25% of the stake in Bharat Immunological shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Bharat Immunological stocks was 0.0% as compared to 0.0% in Sep 2023 with null of 0.0%. The domestic institutional investors (DII) holdings on 31st Mar, 2024 was 0.0% as compared to 0.0% in Sep 2023 with null of 0.0%. Out of the total DII holdings in Bharat Immunological shares 0.0% was held by mutual funds. The rest including public held is 0.0%. Bharat Immunological stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Bharat Immunological Dividend: Ever since 1989, Bharat Immunological dividends has been paid out around 1 times. As on 12 Jun, 2026, 02:24 PM IST, The overall dividend yield for Bharat Immunological stands at 0.0%. The last dividend paid was on September 4, 2002 (Rs. 0.0). The Earnings Per Share (EPS) for quarter ending null is Rs. -4.28.

Bharat Immunological Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 0.16 Cr. of sales and 60.93% of quarterly net profit, there have been multiple ups and downs in the Bharat Immunological stock prices in the past few weeks. For example, Bharat Immunological stock price on 4th of June 2026 was around Rs. 17.52. Bharat Immunological share price now stands at an average of Rs. 17.01. Judging by last week's performance, stock is in down trend.

Bharat Immunological has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Bharat Immunological share.

Historical Prices and Performance:
Bharat Immunological,incorporated in 1989 is a Small Cap company (with a market cap of Rs. 72.63) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Bharat Immunological stock was -19.42%, -8.3%, -53.2%, -49.87% and -18.88% respectively.
The Bharat Immunological share gave a 3 year return of -26.87% as compared to Nifty 50 which gave a return of 24.77%.
Bharat Immunological announced 0.0% final dividend on September 4, 2002.

Key Metrics:
PE Ratio of Bharat Immunological is -4.0
Prices/Sales Ratio of Bharat Immunological is 2.15
Price/Book Ratio of Bharat Immunological is 0.84

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. The PE ratio and PB Ratio of the company are among its competitors stand at -4.0 and 0.84 respectively.

Leadership of Bharat Immunological :
Sandip Kumar Lal is Company Secretary
Y K Gupta is Chairman
Sanjay Kumar Mishra is Managing Director
Alka Sharma is Director
Mohd Aslam is Director
Roshan Lal is Director
Sudhanshu Vrati is Director
Madhu Dikshit is Director